Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diclofenac + capsaicin is a fixed-dose combination topical therapy used primarily for the treatment of osteoarthritis-related pain and inflammation in the knee. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase-1 and -2 (COX-1/COX-2), enzymes responsible for prostaglandin synthesis involved in pain and inflammation. Capsaicin is an active compound from chili peppers that activates TRPV1 receptors on sensory neurons to reduce sensitivity to pain over time. The combination provides both anti-inflammatory effects (from diclofenac) and desensitization of peripheral nociceptors (from capsaicin). It is available as a prepackaged kit containing both agents for topical application directly to affected joints[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diclofenac + capsaicin.